Ident. | Authors (with country if any) | Title |
---|
000014 (2020) |
Nancy Ho-Mahler [États-Unis] ; Beni Turner [États-Unis] ; Michael Eaddy [États-Unis] ; Mark L. Hanke [États-Unis] ; Winnie W. Nelson [États-Unis] | Treatment with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Dermatomyositis/Polymyositis |
000084 (2020) |
Mehrin Jawaid [États-Unis] ; Yael Ross [États-Unis] ; Mohammad Kamran [États-Unis] | PL-7 Antisynthetase Syndrome in Association with Sjögren's, Systemic Lupus Erythematosus, and Rheumatoid Arthritis |
000089 (2020) |
Shou-Di He ; Sheng-Guang Huang ; Hui-Jun Zhu ; Xiao-Guang Luo ; Kang-Han Liao ; Jie-Yao Zhang ; Ning Tan ; De-Yu Li | Oridonin suppresses autophagy and survival in rheumatoid arthritis fibroblast-like synoviocytes |
000090 (2020) |
Yanli Tong [République populaire de Chine] ; Linlin Zheng [République populaire de Chine] ; Pingying Qing [République populaire de Chine] ; Hua Zhao [République populaire de Chine] ; Yanhong Li [République populaire de Chine] ; Linchong Su [République populaire de Chine] ; Qiuping Zhang [République populaire de Chine] ; Yi Zhao [République populaire de Chine] ; Yubin Luo [République populaire de Chine] ; Yi Liu [République populaire de Chine] | Oral Microbiota Perturbations Are Linked to High Risk for Rheumatoid Arthritis |
000106 (2020) |
Dargham B. M. Hammad [Royaume-Uni] ; S. L. Hider [Royaume-Uni] ; Veranja C. Liyanapathirana [Sri Lanka] ; Daniel P. Tonge [Royaume-Uni] | Molecular Characterization of Circulating Microbiome Signatures in Rheumatoid Arthritis |
000133 (2020) |
Sisi Xie ; Shu Li ; Jing Tian ; Fen Li | Iguratimod as a New Drug for Rheumatoid Arthritis: Current Landscape |
000276 (2019) |
Marianne Scheitel [États-Unis] ; Samuel T. Ives [États-Unis] ; Rawad Nasr [États-Unis] ; Marc W. Nolan [États-Unis] | When the plot thickens: a rare complication of rheumatoid arthritis |
000282 (2019) |
Stephanie R. Harrison ; Danyang Li ; Louisa E. Jeffery ; Karim Raza ; Martin Hewison | Vitamin D, Autoimmune Disease and Rheumatoid Arthritis |
000290 (2019) |
Mette Scheller Nissen [Danemark] ; Anna Christine Nilsson [Danemark] ; Jonatan Forsberg [Danemark] ; Jesper Milthers [Danemark] ; Martin Wirenfeldt [Danemark] ; Christian Bonde [Danemark] ; Keld-Erik Byg [Danemark] ; Torkell Ellingsen [Danemark] ; Morten Blaabjerg [Danemark] | Use of Cerebrospinal Fluid Biomarkers in Diagnosis and Monitoring of Rheumatoid Meningitis |
000299 (2019) |
Maria Gabriela Chancay [États-Unis] ; Shirin Nouri Guendsechadze [États-Unis] ; Irene Blanco [États-Unis] | Types of pain and their psychosocial impact in women with rheumatoid arthritis |
000419 (2019) |
Piero Ruscitti [Italie] ; Paola Cipriani [Italie] ; Vasiliki Liakouli [Italie] ; Daniela Iacono [Italie] ; Ilenia Pantano [Italie] ; Domenico Paolo Emanuele Margiotta [Italie] ; Luca Navarini [Italie] ; Giulia Maria Destro Castaniti [Italie] ; Nicola Maruotti [Italie] ; Gerardo Di Scala [Italie] ; Licia Picciariello [Italie] ; Francesco Caso [Italie] ; Sara Bongiovanni [Italie] ; Rosa Daniela Grembiale [Italie] ; Fabiola Atzeni [Italie] ; Raffaele Scarpa [Italie] ; Federico Perosa [Italie] ; Giacomo Emmi [Italie] ; Francesco Paolo Cantatore [Italie] ; Giuliana Guggino [Italie] ; Antonella Afeltra [Italie] ; Francesco Ciccia [Italie] ; Roberto Giacomelli [Italie] | Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study |
000444 (2019) |
Gulsen Ozen [États-Unis] ; Sofia Pedro [États-Unis] ; Rebecca Schumacher [États-Unis] ; Teresa A. Simon [États-Unis] ; Kaleb Michaud [États-Unis] | Safety of abatacept compared with other biologic and conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: data from an observational study |
000461 (2019) |
Kazue Okajima [États-Unis] ; Therese Posas-Mendoza [États-Unis] ; Diane D. Tran [États-Unis] ; Robert A. Hong [États-Unis] | Rheumatoid Arthritis and Cardiac Compression Caused by a Large Fibrotic Intrapericardial Mass and Effusion: A Case Report |
000480 (2019) |
Jaber Emami ; Zahra Ansarypour | Receptor targeting drug delivery strategies and prospects in the treatment of rheumatoid arthritis |
000520 (2019) |
Kai-Lung Chen ; Hsien-Yi Chiu ; Jui-Hsiang Lin ; Jian-De Ye ; Yi-Hsuan Cho ; Ko-Jen Li ; Tsen-Fang Tsai | Prevalence, clinical features and treatment pattern of patients with concurrent diagnoses of rheumatoid arthritis and psoriatic disease: results of a 14-year retrospective study in a tertiary referral center |
000539 (2019) |
Manuel Gallardo-Villagrán [France, Suisse] ; David Yannick Leger [France] ; Bertrand Liagre [France] ; Bruno Therrien [Suisse] | Photosensitizers Used in the Photodynamic Therapy of Rheumatoid Arthritis |
000545 (2019) |
Denis Choquette [Canada] ; Louis Bessette [Canada] ; Evo Alemao [États-Unis] ; Boulos Haraoui [Canada] ; Roelien Postema [Royaume-Uni] ; Jean-Pierre Raynauld [Canada] ; Louis Coupal [Canada] | Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9 years of experience from the Rhumadata® clinical database and registry |
000546 (2019) |
William Buwembo ; Ian Guyton Munabi ; Mark Kaddumukasa ; Haruna Kiryowa ; Ethel Nankya [États-Unis] ; William Evan Johnson [États-Unis] ; Emmy Okello ; Nelson Sewankambo | Periodontitis and Rheumatoid Arthritis in sub-Saharan Africa, gaps and way forward: a systematic review and meta-analysis. |
000634 (2019) |
Johanna Karlsson Sundbaum ; Niclas Eriksson ; P R Hallberg ; Niklas Lehto ; Mia Wadelius ; Eva Baecklund | Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long‐term follow‐up of predictors, surveillance, and outcome in clinical practice |
000660 (2019) |
Guillermo Santoscoy-Ascencio ; Christian Johana Ba Os-Hernández ; José Eduardo Navarro-Zarza ; Jorge Hernández-Bello ; Richard Bucala ; Andres L Pez-Quintero ; Emmanuel Valdés-Alvarado ; Isela Parra-Rojas ; Berenice Illades-Aguiar ; José Francisco Mu Oz-Valle | Macrophage migration inhibitory factor promoter polymorphisms are associated with disease activity in rheumatoid arthritis patients from Southern Mexico |
000678 (2019) |
Kevin L. Winthrop ; Kenneth Saag ; Matthew D. Cascino ; Jinglan Pei ; Ani John ; Angelika Jahreis ; Tmirah Haselkorn ; Daniel E. Furst | Long‐Term Safety of Rituximab in Patients With Rheumatoid Arthritis: Results of a Five‐Year Observational Study |
000709 (2019) |
Patrick Kiely [Royaume-Uni] ; A D Busby [Royaume-Uni] ; E. Nikiphorou [Royaume-Uni] ; K. Sullivan [Royaume-Uni] ; D A Walsh [Royaume-Uni] ; P. Creamer [Royaume-Uni] ; J. Dixey [Royaume-Uni] ; A. Young [Royaume-Uni] | Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts |
000717 (2019) |
Nicole Yang [États-Unis] ; Jie Huang [États-Unis] ; Michelle Frits [États-Unis] ; Christine Iannaccone [États-Unis] ; Michael E. Weinblatt [États-Unis] ; Nader Rifai [États-Unis] ; Nancy Shadick [États-Unis] ; Gary Bradwin [États-Unis] ; Katherine P. Liao [États-Unis] | Interference of tumor necrosis factor inhibitor treatments on soluble tumor necrosis factor receptor 2 levels in rheumatoid arthritis |
000733 (2019) |
Urmila Chandran ; Jenna Reps ; Paul E. Stang ; Patrick B. Ryan | Inferring disease severity in rheumatoid arthritis using predictive modeling in administrative claims databases |
000774 (2019) |
Peter. C. Taylor [Royaume-Uni] ; Alejandro Balsa Criado ; Anne-Barbara Mongey ; Jerome Avouac ; Hubert Marotte ; Rudiger B. Mueller | How to Get the Most from Methotrexate (MTX) Treatment for Your Rheumatoid Arthritis Patient?—MTX in the Treat-to-Target Strategy |
000783 (2019) |
Keyvan Kiakojuri [Iran] ; Behnaz Yousef Ghahari [Iran] ; Sanaz Soltanparast [Iran] ; Mohsen Monadi [Iran] | Hearing status in patients with rheumatoid arthritis |
000787 (2019) |
Yunju Jeong ; Ji-Won Kim ; Hyun Ju You [Corée du Sud] ; Sang-Jun Park ; Jennifer Lee ; Ji Hyeon Ju ; Myeong Soo Park ; Hui Jin ; Mi-La Cho ; Bin Kwon ; Sung-Hwan Park ; Geun Eog Ji | Gut Microbial Composition and Function Are Altered in Patients with Early Rheumatoid Arthritis |
000849 (2019) |
Hiroki Wakabayashi ; Hitoshi Kino ; Makoto Kondo ; Keiichi Yamanaka ; Masahiro Hasegawa ; Akihiro Sudo | Efficacy of subcutaneous tocilizumab in patients with rheumatoid arthritis and systemic sclerosis overlap syndrome: a report of two cases and review of the literature |
000850 (2019) |
Chi Zhang [République populaire de Chine, Hong Kong] ; Daogang Guan [Hong Kong] ; Miao Jiang [République populaire de Chine] ; Chao Liang [Hong Kong] ; Li Li [République populaire de Chine] ; Ning Zhao [République populaire de Chine] ; Qinglin Zha [République populaire de Chine] ; Wandong Zhang [République populaire de Chine] ; Cheng Lu [République populaire de Chine] ; Ge Zhang [Hong Kong] ; Jian Liu [République populaire de Chine] ; Aiping Lu [Hong Kong] | Efficacy of leflunomide combined with ligustrazine in the treatment of rheumatoid arthritis: prediction with network pharmacology and validation in a clinical trial |
000852 (2019) |
Peter C. Taylor ; Didier Saurigny [Royaume-Uni] ; Jiri Vencovsky [République tchèque] ; Tsutomu Takeuchi [Japon] ; Tadashi Nakamura [Japon] ; Galina Matsievskaia [Russie] ; Barbara Hunt [États-Unis] ; Thomas Wagner [Suisse] ; Bernard Souberbielle [Royaume-Uni] | Efficacy and safety of namilumab, a human monoclonal antibody against granulocyte-macrophage colony-stimulating factor (GM-CSF) ligand in patients with rheumatoid arthritis (RA) with either an inadequate response to background methotrexate therapy or an inadequate response or intolerance to an anti-TNF (tumour necrosis factor) biologic therapy: a randomized, controlled trial |
000853 (2019) |
John Tesser [États-Unis] ; Shelly Kafka [États-Unis] ; Raphael J. Dehoratius [États-Unis] ; Stephen Xu [États-Unis] ; Elizabeth C. Hsia [États-Unis] ; Anthony Turkiewicz [États-Unis] | Efficacy and safety of intravenous golimumab plus methotrexate in patients with rheumatoid arthritis aged < 65 years and those ≥ 65 years of age |
000892 (2019) |
Toru Hirano ; Masayuki Nishide ; Naoki Nonaka ; Jun Seita ; Kosuke Ebina [Japon] ; Kazuhiro Sakurada ; Atsushi Kumanogoh | Development and validation of a deep-learning model for scoring of radiographic finger joint destruction in rheumatoid arthritis |
000901 (2019) |
Rajaie Namas ; Abhay Joshi ; Zarmeena Ali ; Jamal Al Saleh ; Mohammed Abuzakouk | Demographic and Clinical Patterns of Rheumatoid Arthritis in an Emirati Cohort from United Arab Emirates |
000905 (2019) |
Jun Wu [République populaire de Chine] ; Tian-Ping Zhang [République populaire de Chine] ; Yu-Lan Zhao [République populaire de Chine] ; Bao-Zhu Li [République populaire de Chine] ; Rui-Xue Leng [République populaire de Chine] ; Hai-Feng Pan [République populaire de Chine] ; Dong-Qing Ye [République populaire de Chine] | Decreased H19, GAS5, and linc0597 Expression and Association Analysis of Related Gene Polymorphisms in Rheumatoid Arthritis |
000913 (2019) |
Poerwati S. Rahajoe ; Menke J. Smit ; Nyoman Kertia ; Johanna Westra ; Arjan Vissink | Cytokines in gingivocrevicular fluid of rheumatoid arthritis patients: A review of the literature |
000914 (2019) |
Yong Fan ; Xinlei Yang ; Juan Zhao ; Xiaoying Sun ; Wenhui Xie ; Yanrong Huang ; Guangtao Li ; Yanjie Hao ; Zhuoli Zhang | Cysteine-rich 61 (Cyr61): a biomarker reflecting disease activity in rheumatoid arthritis |
000989 (2019) |
Ahmed Taha [États-Unis] ; Randa Hazam [États-Unis] ; Jim Tseng [États-Unis] ; Lusine Nahapetyan [États-Unis] ; Masoud Alzeerah [États-Unis] ; Asm Islam [États-Unis] | Bubbles in the Box: Recurrent Pneumothorax From Bronchopleural Fistula in Rheumatoid Arthritis |
000A52 (2019) |
Daniel J. Demizio ; Laura B. Geraldino-Pardilla | Autoimmunity and Inflammation Link to Cardiovascular Disease Risk in Rheumatoid Arthritis |
000B31 (2019) |
Jian-Da Ma [République populaire de Chine] ; Jun Jing [République populaire de Chine] ; Jun-Wei Wang [République populaire de Chine] ; Tao Yan [République populaire de Chine] ; Qian-Hua Li [République populaire de Chine] ; Ying-Qian Mo [République populaire de Chine] ; Dong-Hui Zheng [République populaire de Chine] ; Jin-Long Gao [Australie] ; Ky-Anh Nguyen [Australie] ; Lie Dai [République populaire de Chine] | A novel function of artesunate on inhibiting migration and invasion of fibroblast-like synoviocytes from rheumatoid arthritis patients |
000B32 (2019) |
Feng Tian ; Jing-Yang Li ; Zhen-Hua Wen ; Xiao-Wen Luo ; Li Deng ; Liang Zhang ; Jing-Yun He | A novel etanercept biosimilar Anbainuo plus methotrexate exhibits increased cost-effectiveness compared to conventional disease-modifying anti-rheumatic drugs in treating rheumatoid arthritis patients |
000B36 (2019) |
Felipe Ca As [Colombie] ; Juan David Lopez Ponce De Le N [Colombie] ; Juan Esteban Gomez [Colombie] ; Carlos Alberto Ca As [Colombie] | A giant fibrinoid pericardial mass in a patient with rheumatoid arthritis: a case report |
000B94 (2018) |
Claire Rempenault [France] ; Bernard Combe [France] ; Thomas Barnetche [France] ; Cécile Gaujoux-Viala [France] ; Cédric Lukas [France] ; Jacques Morel [France] ; Charlotte Hua [France] | Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis |
000C55 (2018) |
Rossella Talotta [Italie] ; Fabiola Atzeni [Italie] ; Alberto Batticciotto [Italie] ; Maria Chiara Ditto [Italie] ; Maria Chiara Gerardi [Italie] ; Piercarlo Sarzi-Puttini [Italie] | Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series. |
000D25 (2017) |
Chun Li [République populaire de Chine] ; X R Wang [République populaire de Chine] ; H J Ji [République populaire de Chine] ; X Y Zhang [République populaire de Chine] ; X F Li [République populaire de Chine] ; L Z Wang [République populaire de Chine] ; C H Wang [République populaire de Chine] ; Y F Wang [République populaire de Chine] ; Rong Yang [République populaire de Chine] ; G C Wang [République populaire de Chine] ; Xin Lu [République populaire de Chine] ; Ping Zhu [République populaire de Chine] ; L N Chen [République populaire de Chine] ; H T Jin [République populaire de Chine] ; J T Liu [République populaire de Chine] ; X Y Liu [République populaire de Chine] ; Lin Sun [République populaire de Chine] ; H Y Chen [République populaire de Chine] ; Ping Wei [République populaire de Chine] ; J X Wang [République populaire de Chine] ; L F Cui [République populaire de Chine] ; Rong Shu [République populaire de Chine] ; B L Liu [République populaire de Chine] ; Z L Zhang [République populaire de Chine] ; G T Li [République populaire de Chine] ; Z B Li [République populaire de Chine] ; Jing Yang [République populaire de Chine] ; J F Li [République populaire de Chine] ; Bin Jia [République populaire de Chine] ; F X Zhang [République populaire de Chine] ; J M Tao [République populaire de Chine] ; S L Han [République populaire de Chine] ; J Y Lin [République populaire de Chine] ; M Q Wei [République populaire de Chine] ; X M Liu [République populaire de Chine] ; Dan Ke [République populaire de Chine] ; S X Hu [République populaire de Chine] ; Cong Ye [République populaire de Chine] ; X Y Yang [République populaire de Chine] ; Hao Li [République populaire de Chine] ; C B Huang [République populaire de Chine] ; Ming Gao [République populaire de Chine] ; Bei Lai [République populaire de Chine] ; X F Li [République populaire de Chine] ; L J Song [République populaire de Chine] ; Yi Wang [République populaire de Chine] ; X Y Wang [République populaire de Chine] ; Y D Tang [République populaire de Chine] ; Yin Su [République populaire de Chine] ; Rong Mu [République populaire de Chine] ; Z G Li [République populaire de Chine] | Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China. |
000D64 (2016) |
Miae Be [Corée du Sud] ; Hee Jeong Cha [Corée du Sud] ; Chanho Park [Corée du Sud] ; Yongtae Park [Corée du Sud] ; Hwasik Jung [Corée du Sud] ; Yoeunim Lee [Corée du Sud] ; Yangjin Jegal [Corée du Sud] | Multiple pulmonary cavitary nodules with pyoderma gangrenosum in patient with rheumatoid arthritis. |
000D81 (2016) |
Shino Magaki [États-Unis] ; Edward Chang ; Robert R. Hammond ; Isaac Yang ; Ian R. A. Mackenzie [Canada] ; Benedict T. Chou ; Soo I. Choi ; Joanna C. Jen ; Whitney B. Pope ; David A. Bell [Canada] ; Harry V. Vinters [États-Unis] | Two cases of rheumatoid meningitis |
000D92 (2016) |
Colum Downey [Irlande (pays)] | Serious infection during etanercept, infliximab and adalimumab therapy for rheumatoid arthritis: A literature review |
000E36 (2016) |
Lihua Zhu [République populaire de Chine] ; Lingling Zhou [République populaire de Chine] ; Liang Wang [République populaire de Chine] ; Zhaoxia Li [République populaire de Chine] ; Shuai Lu [République populaire de Chine] ; Lijian Yang [République populaire de Chine] ; Shaohua Chen [République populaire de Chine] ; Bo Li [République populaire de Chine] ; Xiuli Wu [République populaire de Chine] ; Yi Zhou [République populaire de Chine] ; Yangqiu Li [République populaire de Chine] | A20 SNP rs77191406 may be related to secondary cancer for rheumatoid arthritis and systemic lupus erythematosus patients |
000F27 (2015) |
L. Cummins [Australie] ; V. S. Katikireddi [Australie] ; S. Shankaranarayana [Australie] ; K. Y. C. Su [Australie] ; E. Duggan [Australie] ; V. Videm [Australie, Norvège] ; H. Pahau [Australie] ; R. Thomas [Australie] | Safety and retention of combination triple disease‐modifying anti‐rheumatic drugs in new‐onset rheumatoid arthritis |
000F40 (2015) |
Dong In Keum [Corée du Sud] ; Na-Young Yoon [Corée du Sud] ; Won-Soo Lee [Corée du Sud] | Multicentric reticulohistiocytosis misdiagnosed as rheumatoid arthritis |
000F50 (2015) |
Kowoon Joo [Corée du Sud] ; Won Park [Corée du Sud] ; Seong Ryul Kwon [Corée du Sud] ; Mie Jin Lim [Corée du Sud] ; Kyong-Hee Jung [Corée du Sud] | Improvement of vitiligo in a patient with rheumatoid arthritis after hydroxychloroquine treatment |